Cerenovus Enterprise
Device Neurosurgery
PDI 10886704075356
General payments
$15,412
Research payments
$18,376
Through program year 2025, $15,412 in general payments and $18,376 in research payments were reported against Cerenovus Enterprise (Neurosurgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $623 | 7 |
| 2025 | Research | $2,000 | 1 |
| 2024 | General | $1,665 | 14 |
| 2024 | Research | $3,419 | 2 |
| 2023 | General | $5,132 | 28 |
| 2023 | Research | $10,180 | 7 |
| 2022 | General | $3,105 | 42 |
| 2021 | General | $4,887 | 28 |
| 2021 | Research | $2,777 | 2 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
119 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.